3C-P, chemically known as 3,5-Dimethoxy-4-propoxyamphetamine, is a synthetic compound belonging to the substituted amphetamine class. It is structurally related to mescaline and proscaline, sharing a phenethylamine core with methoxy groups at the 3 and 5 positions and a propoxy group at the 4 position of the benzene ring. This structural configuration contributes to its psychoactive properties, primarily characterized by psychedelic and stimulant effects.

Chemical Structure and Properties

• IUPAC-namn: 1-(4-Propoxy-3,5-dimethoxyphenyl)propan-2-amine
• Molekylformel: C14H23NO3
• Molekylvikt: 253.34 g/mol
• Chemical Class: Substituted Amphetamines

Farmakologi

3C-P is believed to exert its effects primarily through agonism of the 5-HT2A receptor, a subtype of serotonin receptor implicated in the modulation of mood, perception, and cognition. Activation of this receptor is commonly associated with the psychedelic experience, leading to altered sensory perception and thought processes. However, detailed studies on the pharmacodynamics and pharmacokinetics of 3C-P are limited, and its exact mechanism of action remains to be fully elucidated.

Dosering och administrering

Due to the limited research and variability in individual responses, dosing should be approached with caution. Anecdotal reports suggest the following oral dosage guidelines:

• Threshold: 5–10 mg
• Ljus: 10–20 mg
• Gemensamt: 20–40 mg
• Stark: 40+ mg

The onset of effects typically occurs within 60 to 150 minutes post-ingestion, with the total duration lasting between 10 to 18 hours. After-effects may persist for an additional 2 to 24 hours. It is crucial to note that individual factors such as body weight, metabolism, and personal sensitivity can significantly influence both the intensity and duration of effects.

Subjective Effects

Physical Effects:

• Stimulering: Users often report increased physical energy, which can manifest as restlessness or an inability to remain still.
• Dämpning av aptitretande: A decrease in hunger sensations is commonly noted.
• Nausea: Some individuals may experience gastrointestinal discomfort, particularly during the onset phase.
• Ökad hjärtfrekvens och blodtryck: Cardiovascular stimulation may occur, necessitating caution in individuals with pre-existing heart conditions.

Visual Effects:

• Enhancements: Increased visual acuity and color enhancement are frequently reported.
• Distortions: Phenomena such as drifting (e.g., melting, flowing, breathing) and color shifting may be experienced.
• Geometry: Complex visual patterns and fractal imagery can occur, especially at higher doses.

Cognitive Effects:

• Thought Acceleration: Rapid thought processes and increased associative thinking are common.
• Conceptual Thinking: Enhanced ability to understand abstract concepts may be noted.
• Anxiety and Paranoia: Negative emotional responses can occur, particularly in unfamiliar or uncomfortable settings.

Auditory Effects:

• Enhancements: Increased sensitivity to sound and music appreciation may be heightened.
• Distortions: Altered perception of sounds, including auditory hallucinations, can occur.

Biverkningar och risker

The safety profile of 3C-P is not well-established due to the paucity of scientific research. Potential side effects, inferred from user reports and the pharmacological properties of related compounds, include:

• Psychological Distress: Anxiety, paranoia, and confusion, particularly at higher doses or in non-supportive environments.
• Cardiovascular Strain: Elevations in heart rate and blood pressure may pose risks to individuals with underlying cardiovascular conditions.
• Neurological Risks: There is a potential risk of seizures, especially in those predisposed or when combined with other substances that lower the seizure threshold.

Harm Reduction Practices

Given the limited data on 3C-P, the following harm reduction strategies are recommended:

• Start Low, Go Slow: Begin with the lowest possible dose to assess individual sensitivity.
• Set and Setting: Ensure a safe, comfortable environment and consider having a sober sitter present.
• Avoid Mixing Substances: Do not combine 3C-P with other psychoactive substances, particularly stimulants, alcohol, or medications like lithium and tramadol, due to the risk of adverse interactions.
• Stay Hydrated: Maintain adequate hydration, but avoid excessive water intake to prevent electrolyte imbalances.
• Health Screening: Individuals with pre-existing medical conditions, especially cardiovascular or neurological disorders, should refrain from using 3C-P.

Legal Status

The legal status of 3C-P varies by jurisdiction and is subject to change. In some regions, it may be classified under analogue laws or specific controlled substance regulations. It is imperative to consult local laws and regulations before considering possession or use.

Slutsats

3C-P is a synthetic psychedelic with limited historical use and minimal scientific study. Its effects are reported to be a combination of stimulation and psychedelic experiences, with a duration that can extend up to 18 hours. Due to the scarcity of data on its safety profile, potential users should exercise extreme caution, adhere strictly to harm reduction practices, and remain informed about the legal implications within their jurisdiction.

Varför köpa 3C-P EU från RECHEMCO?

★ Vi har en lång handelshistoria på marknaden så du drar nytta av vår erfarenhet.
★ 3C-P har testats och kontrollerats.
★ Vi accepterar olika betalningsmetoder som Bitcoin, Monero och banköverföring.

Vad du får när du köper 3C-P EU från RECHEMCO?

- En förseglad aluminiumfoliepåse innehållande högsta kvalitet 3C-P EU
• White and shiny flake
• 99% Purity